...
首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.
【24h】

The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.

机译:慢性阻塞性肺疾病对因慢性心力衰竭住院的患者的预后影响。

获取原文
获取原文并翻译 | 示例

摘要

AIMS: To investigate the prevalence and the prognostic impact of chronic obstructive pulmonary disease (COPD), in patients hospitalised with chronic heart failure (CHF). METHODS AND RESULTS: In an observational study based on longitudinal information from administrative registers, 1020 patients aged >or=60 years, who were chronically treated for and hospitalised with CHF were identified and followed-up for major events up to 1 year. Median age was 80 years, half of the patients were female and 241 patients (23.6%) had concomitant COPD. There were no differences in the prevalence of cardiovascular and non-cardiovascular comorbidities between CHF patients with or without COPD. However, COPD patients were more often male (60.6% vs. 46.3%), more frequently treated with diuretics (95.9% vs. 91.5%) but less often exposed to beta-blockers (16.2% vs. 22.0%). Significantly higher adjusted in-hospital (HR 1.50 [95%CI 1.00-2.26]) and out-of-hospital (1.42 [1.09-1.86]) mortality rates were found in CHF patients with concomitant COPD. A higher occurrence of non-fatal AMI/stroke/rehospitalisation for CHF (1.26 [1.01-1.58]) as well as hospitalisation for CHF (1.35 [1.00-1.82]) was associated with COPD. CONCLUSIONS: COPD is a frequent concomitant disease in patients with heart failure and it is an independent short-term prognostic indicator of mortality and cardiovascular comorbidity in patients who have been admitted to hospital for heart failure.
机译:目的:研究慢性阻塞性肺疾病(COPD)在住院的慢性心力衰竭(CHF)患者中的患病率及其对预后的影响。方法和结果:在一项基于行政登记簿纵向信息的观察性研究中,确定了1020名≥60岁的患者,这些患者经慢性心力衰竭接受了慢性治疗并住院治疗,并随访了长达1年的重大事件。中位年龄为80岁,一半为女性,241例(23.6%)伴有COPD。患有或未患有COPD的CHF患者之间的心血管和非心血管合并症患病率无差异。但是,COPD患者中男性较多(60.6%对46.3%),利尿剂治疗更为频繁(95.9%对91.5%),但很少接触β-受体阻滞剂(16.2%对22.0%)。在伴有COPD的CHF患者中,调整后的院内死亡率(HR 1.50 [95%CI 1.00-2.26])和院外(1.42 [1.09-1.86])死亡率显着较高。 CHPD与非致命性AMI /卒中/再住院的发生率较高(1.26 [1.01-1.58]),以及CHF的住院治疗率(1.35 [1.00-1.82])与COPD相关。结论:COPD是心力衰竭患者的常见伴随疾病,并且是因心力衰竭入院的患者死亡率和心血管合并症的独立短期预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号